References
- Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003–2004. J Am Acad Dermatol. 2009;60:218–24
- Callis K, Carlin C, Krueger G. Correlation of National Psoriasis Foundation Score components with quality of life measures in psoriasis [POSTER]. The International Investigative Dermatology: Joint Meeting of the ESDR, JSID, and SID; was held in Miami, FL, April 2003
- Long CC, Finlay AY, Averill RW. The rule of hand: 4 hand areas = 2 FTU = 1 g. Arch Dermatol. 1992;128:1129–30
- Fredriksson T, Pettersson U. Severe psoriasisoral therapy with a new retinoid. Dermatologica 1978;157:238–44
- Chaudhari U, Romano P, Mulcahy LD, et al. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet 2001;357:1842–7
- Ware JE, Jr Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473–83
- Aday LA, Cornelius LJ. Designing and Conducting Health Surveys: A Comprehensive Guide, 3rd ed. San Francisco: Jossey-Bass, 2006
- Chassany O, Cualin C. Health-Related Quality of Life and Patient-Reported Outcomes: Scientific and Useful Outcome Criteria. Paris, France: Springer, 2003
- Otuki MF, Reis RC, Cabrini D, et al. Patient-reported outcomes in psoriasis research and practice. Br J Dermatol. 2011;165:1361–2
- Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–16
- Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes. 26 2004;2:12
- Mona L, Martin M. Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure. J Am Acad Dermatol. 2012;2012:66
- Augustin M, Radtke MA, Zschocke I, et al. The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases. Arch Dermatol Res. 2009;301:561–71
- Storm A, Andersen SE, Benfeldt E, Serup J. One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol. 2008;59:27–33
- Aday LA. Designing and Conducting Health Surveys: A Comprehensive Guide, 2nd ed. San Francisco, CA: Jossey-Bass Publishers, 1996